varenicline has been researched along with Recrudescence in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (24.49) | 29.6817 |
| 2010's | 30 (61.22) | 24.3611 |
| 2020's | 7 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kotz, D; Spigt, M; van Rossem, C; van Schayck, OCP; Viechtbauer, W | 1 |
| Borchardt, B; Hajek, P; Schoberberger, R | 1 |
| Cinciripini, P; Colder, C; George, TP; Hawk, LW; Mahoney, MC; Schnoll, R; Swan, GE; Tonkin, SS; Tyndale, RF | 1 |
| Huang, P; Jiaerken, Y; Li, K; Luo, X; Qian, W; Shen, Z; Wang, C; Wang, S; Yang, Y; Zeng, Q; Zhang, M; Zhou, C | 1 |
| Filipponi, A; Giordano, P; Giulietti, F; Iacoacci, C; Rosettani, G; Sarzani, R; Spannella, F | 1 |
| Adamcekova, Z; Kralikova, E; Kuhn, M; Noland, D; Pankova, A; Stepankova, L; Zvolska, K | 1 |
| Caldwell, DM; Dalili, MN; Keeney, E; López-López, JA; Munafò, MR; Phillippo, DM; Stevenson, M; Thomas, KH; Welton, NJ | 1 |
| Abramson, BL; Baril, JF; Bata, I; Cassavar, D; Clarke, A; Dehghani, P; Dion, D; Eisenberg, MJ; Grondin, FR; Habib, B; Haught, H; Iskander, A; Lambert, C; Lauzon, C; Madan, M; Mehta, SR; Old, W; Roy, N; Srivastava, N; Windle, SB | 1 |
| Cornuz, J; Csajka, C; Dobrinas, M; Eap, CB; Gholamrezaee, M; Glatard, A; Lubomirov, R | 1 |
| Abe, Y; Imai, T; Katayama, K; Kusakabe, A; Nawa, T; Ohkawa, K; Sakakibara, M | 1 |
| Brown, J; Jackson, SE; McGowan, JA; Proudfoot, H; Shahab, L; Ubhi, HK; West, R | 1 |
| Benowitz, NL; Chen, M; Cinciripini, PM; George, TP; Hawk, LW; Lerman, C; Li, L; Robinson, JD; Schnoll, RA; Tyndale, RF | 1 |
| Cho, B; Park, PW; Wajsbrot, D; Wang, C; Xiao, D | 1 |
| Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Arteaga, C; Nakamura, M; Ohkura, M; Oshima, A; Suwa, K | 1 |
| Hoogsteder, PH; Kotz, D; van Schayck, OC; van Spiegel, PI; Viechtbauer, W | 1 |
| Gonzales, D; Hajek, P; McRae, TD; Nackaerts, K; Pliamm, L; Treadow, J; Tseng, LJ | 1 |
| Castillo-Fernández, E; Lara-Fernández, M; López-Quirantes, EM; López-Torrecillas, F; Nieto-Ruiz, A; Velasco-Ortuño, S | 1 |
| Agboola, SA; Coleman, T; Leonardi-Bee, J; McNeill, A | 1 |
| Cummins, SE; Gamst, AC; Ikeda, T; Wong, S; Zhu, SH | 1 |
| Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö | 1 |
| Klein, JW | 1 |
| Chaudhri, N; Heidari-Jam, A; Lacroix, F; Maddux, JN; Pettorelli, A | 1 |
| Ahluwalia, JS; Dogar, O; Jawad, M; Kanaan, M; Khan, A; Mansoor, S; Siddiqi, K; Zahid, R | 1 |
| Huang, P; Qian, W; Shen, Z; Wang, C; Yang, Y; Zhang, M | 1 |
| Popkin, MK | 1 |
| Catz, SL; Deprey, TM; Halperin, AC; Jack, LM; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM | 1 |
| Galanti, LM | 1 |
| Cahill, K; Lancaster, T; Stead, L | 1 |
| Fukuda, T; Igarashi, A; Takuma, H; Tsutani, K | 1 |
| Dugan, SE; Garrison, GD | 1 |
| Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J | 1 |
| Frey, J; Gur, R; Jepson, C; Lerman, C; Loughead, J; Patterson, F; Perkins, K; Siegel, S; Strasser, AA | 1 |
| Mead, AN; O'Connor, EC; Parker, D; Rollema, H | 1 |
| Anthenelli, RM; Arteaga, C; Heffner, JL; Lee, TC | 1 |
| Fagerström, K; Gilljam, H; Messig, M; Metcalfe, M; Tonstad, S | 1 |
| De Vries, TJ; De Vries, W; Pattij, T; Riga, D; Schetters, D; Schoffelmeer, AN; Stegeman, M; van Mourik, Y; Wouda, JA | 1 |
| Caro, JJ; Davies, S; Ishak, KJ; Kinter, ET; Marton, JP; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Anderson, BJ; Audet, DA; de Dios, MA; Stanton, C; Stein, M | 1 |
| Abrishami, A; Chapman, KR; Chung, F; Friedman, Z; Selby, P; Wong, J; Yang, Y; Zaki, A | 1 |
| Bansal-Travers, M; Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, AJ; Kasza, KA; McNeill, AD | 1 |
| Brown, VL; Cinciripini, PM; Cui, Y; Dani, JA; Engelmann, JM; Karam-Hage, M; Kosten, TR; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Aveyard, P | 1 |
| Kohen, I; Kremen, N | 1 |
| Freedman, R | 1 |
| Moorman, KL; Whitley, HP | 1 |
| Tyndale, R | 1 |
8 review(s) available for varenicline and Recrudescence
| Article | Year |
|---|---|
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
Topics: Alkaloids; Azocines; Bupropion; Clinical Decision-Making; Electronic Nicotine Delivery Systems; Humans; Quinolizines; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
Topics: Bupropion; Cost-Benefit Analysis; Depression; Drug Costs; Electronic Nicotine Delivery Systems; Humans; Markov Chains; Models, Economic; Monte Carlo Method; Network Meta-Analysis; Nicotinic Agonists; Quality-Adjusted Life Years; Recurrence; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline | 2021 |
Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
Topics: Biobehavioral Sciences; Bupropion; Follow-Up Studies; Humans; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials.
Topics: Adult; Humans; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2015 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Tobacco smoking cessation management: integrating varenicline in current practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Varenicline: a first-line treatment option for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
15 trial(s) available for varenicline and Recrudescence
| Article | Year |
|---|---|
Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving.
Topics: Adult; Benzazepines; Cigarette Smoking; Craving; Humans; Quinoxalines; Recurrence; Smoking Cessation; Varenicline | 2022 |
Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Blood Pressure; Body Mass Index; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Recurrence; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Weight Gain | 2017 |
Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.
Topics: Adult; Combined Modality Therapy; Counseling; Craving; Female; Humans; Male; Middle Aged; Recurrence; Reinforcement, Psychology; Smoking; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2019 |
Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice.
Topics: Adolescent; Adult; Asia; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Medication Adherence; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Benzazepines; Counseling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netherlands; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Vaccines; Varenicline; Young Adult | 2014 |
Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Australia; Benzazepines; Canada; Chi-Square Distribution; Counseling; Double-Blind Method; Europe; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Recurrence; Retreatment; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline; Young Adult | 2014 |
The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial.
Topics: Affect; Behavior Therapy; Clinical Protocols; Combined Modality Therapy; Double-Blind Method; Humans; Nicotinic Agonists; Pakistan; Recurrence; Research Design; Smokers; Smoking Cessation; Smoking Water Pipes; Time Factors; Tobacco Use Cessation Devices; Tobacco, Waterpipe; Treatment Outcome; Varenicline | 2017 |
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
Topics: Adult; Benzazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Internet; Male; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Sex Factors; Smoking Cessation; Smoking Prevention; Telephone; Varenicline | 2009 |
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
Topics: Adult; Aged; Benzazepines; Combined Modality Therapy; Counseling; Female; Humans; Japan; Male; Markov Chains; Middle Aged; Models, Economic; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2009 |
Working memory deficits predict short-term smoking resumption following brief abstinence.
Topics: Adolescent; Adult; Attention; Benzazepines; Female; Humans; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Predictive Value of Tests; Psychomotor Performance; Quinoxalines; Recurrence; Regression Analysis; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials.
Topics: Adult; Alcohol Drinking; Benzazepines; Data Interpretation, Statistical; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
Topics: Adult; Benzazepines; Cotinine; Double-Blind Method; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Recurrence; Saliva; Tobacco Use Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; Varenicline | 2010 |
Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.
Topics: Adult; Behavior Therapy; Benzazepines; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Recurrence; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cotinine; Counseling; Double-Blind Method; Female; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Quinoxalines; Recurrence; Sample Size; Smoking; Smoking Cessation; Telephone; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2012 |
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline | 2013 |
26 other study(ies) available for varenicline and Recrudescence
| Article | Year |
|---|---|
Validity of urges to smoke measures in predicting smoking relapse during treatment in primary care.
Topics: Humans; Primary Health Care; Recurrence; Smoking; Smoking Cessation; Varenicline | 2021 |
Are "Delayed Quitters" More Likely to Relapse Than Smokers Who Quit on Their Target Quit Date? A Retrospective Analysis of Clinical Records.
Topics: Female; Humans; Recurrence; Retrospective Studies; Smokers; Smoking Cessation; Varenicline | 2022 |
Increased striatal functional connectivity is associated with improved smoking cessation outcomes: A preliminary study.
Topics: Adult; Brain; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2021 |
Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time.
Topics: Ambulatory Care Facilities; Cohort Studies; Czech Republic; Female; Humans; Male; Recurrence; Retrospective Studies; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy.
Topics: Adult; Cotinine; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Tobacco Products; Varenicline | 2017 |
Two-step progression of varenicline-induced autoimmune hepatitis.
Topics: Chemical and Drug Induced Liver Injury; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Liver; Lymphocytes; Middle Aged; Nicotinic Agonists; Recurrence; Smoking Cessation; Varenicline; Withholding Treatment | 2018 |
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers.
Topics: Adult; Aged; Asian People; Chronic Disease; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
The role of impulsivity in dropout from treatment for cigarette smoking.
Topics: Adult; Benzazepines; Case-Control Studies; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Delay Discounting; Female; Humans; Impulsive Behavior; Male; Middle Aged; Patient Dropouts; Personality; Personality Inventory; Quinoxalines; Recurrence; Smoking; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Smoking cessation and varenicline. Do not expose or re-expose patients to its serious adverse effects!
Topics: Benzazepines; Drug Administration Schedule; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Retreatment; Risk Assessment; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smokers; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult | 2016 |
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline | 2015 |
Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens.
Topics: Animals; Conditioning, Classical; Cues; Discrimination, Psychological; Drug-Seeking Behavior; Ethanol; Extinction, Psychological; Male; Nucleus Accumbens; Rats, Long-Evans; Recurrence; Varenicline | 2017 |
Increased network centrality as markers of relapse risk in nicotine-dependent individuals treated with varenicline.
Topics: Adult; Brain; Brain Mapping; Echo-Planar Imaging; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Nicotinic Agonists; Oxygen; Recurrence; Tobacco Use Disorder; Varenicline | 2017 |
Exacerbation of recurrent depression as a result of treatment with varenicline.
Topics: Aged; Benzazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking Cessation; Varenicline | 2008 |
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2009 |
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
Topics: Animals; Association Learning; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Exploratory Behavior; Food; Male; Models, Animal; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Recurrence; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder; Varenicline | 2010 |
Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
Topics: Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Ethanol; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Rats, Wistar; Reaction Time; Recurrence; Reinforcement Schedule; Self Administration; Sucrose; Varenicline | 2011 |
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
Topics: Adult; Benzazepines; Clinical Trials as Topic; Female; Health Care Costs; Humans; Male; Models, Statistical; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
Topics: Adolescent; Adult; Age Distribution; Aged; Australia; Benzazepines; Bupropion; Canada; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2013 |
Alpha oscillations in response to affective and cigarette-related stimuli in smokers.
Topics: Adult; Attention; Benzazepines; Brain; Bupropion; Cues; Demography; Electroencephalography Phase Synchronization; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Photic Stimulation; Quinoxalines; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Varenicline | 2013 |
The neurobiological basis for partial agonist treatment of nicotine dependence.
Topics: Benzazepines; Humans; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2006 |
Varenicline-induced manic episode in a patient with bipolar disorder.
Topics: Benzazepines; Bipolar Disorder; Humans; Male; Middle Aged; Quinoxalines; Recurrence; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2007 |
Exacerbation of schizophrenia by varenicline.
Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline | 2007 |
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Drug Combinations; Drug Interactions; Humans; Male; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Drug addiction: a critical problem calling for novel solutions.
Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline | 2008 |